Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.

Shen X, Zaorsky NG, Mishra MV, Foley KA, Hyslop T, Hegarty S, Pizzi LT, Dicker AP, Showalter TN.

Future Oncol. 2012 Jan;8(1):37-54. doi: 10.2217/fon.11.131. Review.

PMID:
22149034
[PubMed - indexed for MEDLINE]
2.

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.

Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, Wilt T, Ziegler K.

Evid Rep Technol Assess (Summ). 1999 May;(4):i-x, 1-246, I1-36, passim. Review.

PMID:
11098244
[PubMed - indexed for MEDLINE]
Free Article
3.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
[PubMed - indexed for MEDLINE]
4.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
5.

A systematic review of randomized trials in localized prostate cancer.

Alibhai SM, Klotz LH.

Can J Urol. 2004 Feb;11(1):2110-7. Review.

PMID:
15003149
[PubMed - indexed for MEDLINE]
6.

Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review.

Hummel S, Paisley S, Morgan A, Currie E, Brewer N.

Health Technol Assess. 2003;7(33):iii, ix-x, 1-157. Review.

PMID:
14609482
[PubMed - indexed for MEDLINE]
Free Article
7.

Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).

Konski A, Sherman E, Krahn M, Bremner K, Beck JR, Watkins-Bruner D, Pilepich M.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):788-94.

PMID:
16109464
[PubMed - indexed for MEDLINE]
8.

Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin.

Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H.

J Urol. 2000 Apr;163(4):1178-82.

PMID:
10737490
[PubMed - indexed for MEDLINE]
9.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31.

PMID:
16029788
[PubMed - indexed for MEDLINE]
10.

Comparative effectiveness research in localized prostate cancer treatment.

Hoffman RM, Penson DF, Zietman AL, Barry MJ.

J Comp Eff Res. 2013 Nov;2(6):583-93. doi: 10.2217/cer.13.66. Review.

PMID:
24236797
[PubMed - indexed for MEDLINE]
11.

Endocrine treatment of prostate cancer.

Tammela T.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Epub 2004 Dec 31. Review.

PMID:
15663992
[PubMed - indexed for MEDLINE]
12.

Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostate.

Kobeissi BJ, Gupta M, Perez CA, Dopuch N, Michalski JM, Van Antwerp G, Gerber R, Wasserman TH.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):593-603.

PMID:
9486609
[PubMed - indexed for MEDLINE]
13.

Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: clinical and cost-utility analyses.

Quigley MM, Mate TP, Sylvester JE.

Urol Oncol. 2009 Sep-Oct;27(5):473-82. doi: 10.1016/j.urolonc.2008.04.017. Epub 2008 Jul 14.

PMID:
18625565
[PubMed - indexed for MEDLINE]
14.

High-dose external beam radiation for localized prostate cancer: current status and future challenges.

Nguyen PL, Zietman AL.

Cancer J. 2007 Sep-Oct;13(5):295-301. Review.

PMID:
17921728
[PubMed - indexed for MEDLINE]
15.

Treatment of locally advanced prostate cancer: is chemotherapy the next step?

Oh WK, Kantoff PW.

J Clin Oncol. 1999 Nov;17(11):3664-75. Review.

PMID:
10550165
[PubMed - indexed for MEDLINE]
Free Article
16.

Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.

Norderhaug I, Dahl O, Høisaeter PA, Heikkilä R, Klepp O, Olsen DR, Kristiansen IS, Waehre H, Bjerklund Johansen TE.

Eur Urol. 2003 Jul;44(1):40-6. Review.

PMID:
12814673
[PubMed - indexed for MEDLINE]
17.

A cost-outcome analysis of long-term adjuvant goserelin in addition to radiotherapy for locally advanced prostate cancer.

Samant RS, Dunscombe PB, Roberts GH.

Urol Oncol. 2003 May-Jun;21(3):171-7.

PMID:
12810202
[PubMed - indexed for MEDLINE]
18.

Cost effectiveness of risk-prediction tools in selecting patients for immediate post-prostatectomy treatment.

Zubek VB, Konski A.

Mol Diagn Ther. 2009;13(1):31-47. doi: 10.2165/01250444-200913010-00006.

PMID:
19351214
[PubMed - indexed for MEDLINE]
19.

Neoadjuvant hormonal therapy in carcinoma of the prostate.

Lee HH, Warde P, Jewett MA.

BJU Int. 1999 Mar;83(4):438-48. Review.

PMID:
10210568
[PubMed - indexed for MEDLINE]
20.

Adjuvant radiotherapy after radical prostatectomy: evidence and analysis.

Raldow A, Hamstra DA, Kim SN, Yu JB.

Cancer Treat Rev. 2011 Apr;37(2):89-96. doi: 10.1016/j.ctrv.2010.07.001. Epub 2010 Jul 27. Review.

PMID:
20667660
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk